Intra-familial variation in clinical manifestations and response to ephedrine in siblings with congenital myasthenic syndrome caused by novel COLQ mutations

Dev Med Child Neurol. 2010 Oct;52(10):e243-4. doi: 10.1111/j.1469-8749.2010.03663.x. Epub 2010 Mar 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetylcholinesterase / deficiency
  • Acetylcholinesterase / genetics*
  • Adolescent
  • Asian People / genetics*
  • Central Nervous System Stimulants / therapeutic use
  • Collagen / genetics*
  • Ephedrine / therapeutic use*
  • GPI-Linked Proteins / deficiency
  • Heterozygote
  • Humans
  • Male
  • Muscle Proteins / genetics*
  • Muscle Strength / drug effects*
  • Mutation*
  • Myasthenic Syndromes, Congenital / drug therapy*
  • Myasthenic Syndromes, Congenital / genetics*
  • Myasthenic Syndromes, Congenital / physiopathology
  • Neural Conduction / drug effects
  • RNA Splicing
  • Sympathomimetics / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Central Nervous System Stimulants
  • GPI-Linked Proteins
  • Muscle Proteins
  • Sympathomimetics
  • Collagen
  • ACHE protein, human
  • Acetylcholinesterase
  • COLQ protein, human
  • Ephedrine